Centre Hospitalier Lyon-Sud - Service d'Hematologie clinique

Pierre-Bénite 69495

0 studies enrolling now · 3 studies all time

What they study most

Multiple Myeloma, Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

Studies at this site

• A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments — Recruiting now
• MagnetisMM-3: Study Of Elranatamab (PF-06863135) Monotherapy in Participants With Multiple Myeloma Who Are Refractory to at Least One PI, One IMiD and One Anti-CD38 mAb — Running, not enrolling
• Study of Effectiveness of Axicabtagene Ciloleucel Compared to Standard of Care Therapy in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma — Completed